Legal & General Group Plc decreased its position in Amrize Ltd (NYSE:AMRZ – Free Report) by 9.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 2,680,769 shares of the company’s stock after selling 267,463 shares during the period. Legal & General Group Plc’s holdings in Amrize were worth $146,952,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. State of Wyoming bought a new stake in Amrize in the 3rd quarter valued at $32,000. Laurel Wealth Advisors LLC bought a new stake in Amrize during the 4th quarter worth about $34,000. US Bancorp DE bought a new stake in shares of Amrize in the 3rd quarter valued at about $38,000. Costello Asset Management INC bought a new stake in shares of Amrize in the 3rd quarter valued at about $44,000. Finally, Jones Financial Companies Lllp bought a new stake in shares of Amrize in the 3rd quarter valued at about $53,000.
Insider Activity
In other Amrize news, CTO Roald Brouwer bought 3,000 shares of the firm’s stock in a transaction on Wednesday, March 11th. The shares were purchased at an average price of $58.72 per share, for a total transaction of $176,160.00. Following the transaction, the chief technology officer directly owned 16,257 shares in the company, valued at approximately $954,611.04. This trade represents a 22.63% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Mario Gross bought 3,200 shares of the firm’s stock in a transaction on Friday, March 13th. The shares were acquired at an average price of $55.29 per share, for a total transaction of $176,928.00. Following the transaction, the insider owned 30,947 shares in the company, valued at approximately $1,711,059.63. This represents a 11.53% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last 90 days, insiders have acquired 131,554 shares of company stock worth $7,152,069. Insiders own 0.54% of the company’s stock.
Analyst Ratings Changes
Get Our Latest Report on Amrize
Amrize Stock Down 0.2%
Shares of AMRZ opened at $52.98 on Friday. Amrize Ltd has a 52 week low of $44.12 and a 52 week high of $65.94. The firm has a market cap of $29.30 billion and a P/E ratio of 25.35. The firm’s 50-day simple moving average is $54.44 and its 200 day simple moving average is $55.16. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.89 and a current ratio of 1.40.
Amrize (NYSE:AMRZ – Get Free Report) last announced its earnings results on Wednesday, April 29th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.02). Amrize had a return on equity of 9.84% and a net margin of 9.70%.The business had revenue of $2.18 billion for the quarter. The company’s revenue for the quarter was up 4.7% on a year-over-year basis. On average, analysts forecast that Amrize Ltd will post 2.76 earnings per share for the current year.
Amrize Cuts Dividend
The firm also recently announced a dividend, which was paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th were given a dividend of $0.11 per share. The ex-dividend date was Tuesday, May 12th. Amrize’s dividend payout ratio is presently 21.05%.
About Amrize
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Read More
- Five stocks we like better than Amrize
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ – Free Report).
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
